In terms of tumor treatment strategies, since HA accumulation is often observed in the tumor stroma where it contributes to cancer progression, PEGylated human recombinant PH20 hyaluronidase (PEGPH20) has been developed as an anticancer therapy and is currently in clinical trials [69]. Here, SPAM1 is linked to neoplasm.